These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2472923)

  • 1. C5 neoepitopes appearing during activation.
    Inoue K
    Complement Inflamm; 1989; 6(3):219-22. PubMed ID: 2472923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid and simple measurement of human C5a-des-Arg level in plasma or serum using monoclonal antibodies.
    Takeda J; Kinoshita T; Takata Y; Kozono H; Tanaka E; Hong K; Inoue K
    J Immunol Methods; 1987 Aug; 101(2):265-70. PubMed ID: 3611800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
    Gerard C; Hugli TE
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1833-7. PubMed ID: 6940191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of complement activation in rabbit plasma or serum using monoclonal antibodies against C5a.
    Bergh K; Iversen OJ
    Scand J Immunol; 1989 Mar; 29(3):333-41. PubMed ID: 2470136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of human C5a des arg by immunoadsorbent and molecular sieve chromatography.
    Manderino GL; Suarez AF; Kunkel SL; Ward PA; Hirata AA; Showell H
    J Immunol Methods; 1982 Aug; 53(1):41-50. PubMed ID: 6752282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human C5a and C5a des Arg exhibit chemotactic activity for fibroblasts.
    Senior RM; Griffin GL; Perez HD; Webster RO
    J Immunol; 1988 Nov; 141(10):3570-4. PubMed ID: 3183381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A specific enzyme-linked immunosorbent assay (ELISA) for the determination of human C5a antigen.
    Kunkel SL; Manderino GL; Marasco W; Kaercher K; Hirata AA; Ward PA
    J Immunol Methods; 1983 Sep; 62(3):305-14. PubMed ID: 6193199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg.
    Marder SR; Chenoweth DE; Goldstein IM; Perez HD
    J Immunol; 1985 May; 134(5):3325-31. PubMed ID: 3884709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eculizumab-C5 complexes express a C5a neoepitope in vivo: Consequences for interpretation of patient complement analyses.
    Nilsson PH; Thomas AM; Bergseth G; Gustavsen A; Volokhina EB; van den Heuvel LP; Barratt-Due A; Mollnes TE
    Mol Immunol; 2017 Sep; 89():111-114. PubMed ID: 28610663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological properties of human C5a: selected in vitro and in vivo studies.
    Yancey KB
    Clin Exp Immunol; 1988 Feb; 71(2):207-10. PubMed ID: 3280183
    [No Abstract]   [Full Text] [Related]  

  • 11. The C5a receptor of neutrophils and macrophages.
    Chenoweth DE; Goodman MG
    Agents Actions Suppl; 1983; 12():252-73. PubMed ID: 6573117
    [No Abstract]   [Full Text] [Related]  

  • 12. Amino-acid sequence and disulfide linkages of the anaphylatoxin, des-Arg omega-C5a, from porcine serum.
    Zimmermann B; Vogt W
    Hoppe Seylers Z Physiol Chem; 1984 Feb; 365(2):151-8. PubMed ID: 6714942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attachment of human C5a des Arg to its cochemotaxin is required for maximum expression of chemotactic activity.
    Perez HD; Chenoweth DE; Goldstein IM
    J Clin Invest; 1986 Dec; 78(6):1589-95. PubMed ID: 3782473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of monoclonal antibodies against the human anaphylatoxin C5a des Arg and their application in the neoepitope-specific sandwich-ELISA for the quantification of C5a des Arg in plasma.
    Bergh K; Iversen OJ
    J Immunol Methods; 1992 Jul; 152(1):79-87. PubMed ID: 1379278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologically active products of complement and acute lung injury in patients with the sepsis syndrome.
    Weinberg PF; Matthay MA; Webster RO; Roskos KV; Goldstein IM; Murray JF
    Am Rev Respir Dis; 1984 Nov; 130(5):791-6. PubMed ID: 6497161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the interaction of human C5a and C5a des Arg with human monocytes and neutrophils: flow cytometric and chemotaxis studies.
    Yancey KB; Lawley TJ; Dersookian M; Harvath L
    J Invest Dermatol; 1989 Feb; 92(2):184-9. PubMed ID: 2493055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of murine monoclonal antibodies that recognize neutralizing epitopes on human C5a.
    Larrick JW; Wang J; Fendly BM; Chenoweth DE; Kunkel SL; Deinhart T
    Infect Immun; 1987 Aug; 55(8):1867-72. PubMed ID: 2440808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemoattractant des-Arg74-C5a regulates the expression of its own receptor on a monocyte-like cell line.
    Barker MD; Jose PJ; Williams TJ; Burton DR
    Biochem J; 1986 Jun; 236(2):621-4. PubMed ID: 3019322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Airways hyperreactivity and inflammation produced by aerosolization of human C5A des arg.
    Irvin CG; Berend N; Henson PM
    Am Rev Respir Dis; 1986 Oct; 134(4):777-83. PubMed ID: 3767132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory properties of human C5a and C5a des Arg/ in mast cell-depleted human skin.
    Swerlick RA; Yancey KB; Lawley TJ
    J Invest Dermatol; 1989 Sep; 93(3):417-22. PubMed ID: 2527912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.